Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Vortioxetine

508233-74-7C18H22N2S298.455 g/mol

An N-arylpiperazine in which the aryl group is specified as 2-[(2,4-dimethylphenyl)sulfanyl]phenyl. Used (as its hydrobromide salt) for treatment of major depressive disorder. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number508233-74-7ChEBI ↗
Molecular formulaC18H22N2SChEBI ↗
Molar mass298.455 g/molChEBI ↗
Monoisotopic mass298.15037 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:76016ChEBI ↗

Cross-source molecular data

PubChem
Molar mass298.4 g/molPubChem ↗
Exact mass298.15036988 DaPubChem ↗
Computed XLogP4.2PubChem ↗
Topological polar surface area (Ų)40.6PubChem ↗
H-bond donors1PubChem ↗
H-bond acceptors3PubChem ↗
Rotatable bonds3PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Molar masses differ between sources. Check isotope composition, source conventions and the original records before calculating a precise quantity.

Names & structural identifiers

Copy any identifier
vortioxetine
1-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazine
YQNWZWMKLDQSAC-UHFFFAOYSA-N
Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1
InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3

Names & synonyms

1-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazinevortioxetinavortioxetinum

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

antidepressantanxiolytic drugantipsychotic agentserotonergic agonistserotonergic antagonist

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00335059 mol

Uses 298.455 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 18 atoms
72.44%
S
Sulfur · 1 atom
10.75%
N
Nitrogen · 2 atoms
9.39%
H
Hydrogen · 22 atoms
7.43%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder. ↗The Journal of pharmacology and experimental therapeutics · 2012 Mar · PMID 22171087
WO2008113359 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:76016

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 9966051 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.